Intranet Campus web

Awarded set of papers


1) Flachs P, Rossmeisl M , Bryhn  M , and  Kopecký J. 2009. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clinical Science 116:1-16

 

2) Rossmeisl M, Jeleník T, Jilková Z, Slamová K, Kůs V, Hensler M, Medříková D,  Povyšíl C, Flachs P, Mohamed-Ali V, Bryhn M, Berge K, Holmeide AK, and Kopecký J. 2009. Prevention and reversal of obesity and glucose intolerance in mice by DHA-derivatives. Obesity 17: 1023-1031

 

3) van Schothorst EM, Flachs P, Franssen-van Hal NL, Kuda O, Bunschoten A, Molthoff J,  Vink C, Hooiveld G J, Kopecký J, and Keijer J. 2009. Induction of lipid oxidation by polyunsaturated fatty acids of marine origin in small intestine of mice fed a high-fat diet. BMC Genomics 10 :110

 

4) Kuda O, Jeleník T, Jilková Z, Flachs P, Rossmeisl M, Hensler M, Kazdová L, Ogston N, Baranowski M, Gorski J, Janovská P, Kůs V, Polák J, Mohamed-Ali V, Burcelin R, Cinti S, Bryhn M, and  Kopecký J. 2009.  n-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia 52 :941-51

 

5) Kuda O,  Stankova B, Tvrzicka E, Hensler M, Jelenik T, Rossmeisl M, Flachs P, Kopecky J. 2009. Prominent role of liver in elevated plasma palmitoleate levels in response to rosiglitazone in mice fed high-fat diet. Journal of Physiology and Pharmacology 60: 135-140    

 

6) Kopecký J, Rossmeisl M, Flachs P, Kuda O, Jilková Z, Staňková B, Tvrzická E, and Bryhn M. 2009. n-3 polyunsaturated fatty acids: bioavailability and modulation of adipose tissue function. Proc Nutr Soc 68: 361-369

 

7) Jeleník T, Rossmeisl M, Kuda O,  Macek Jilková Z, Medřiková D, Kůs V, Hensler M, Janovská P, Mikšík I, Baranowski M, Gorski J, Hébrard S, Jensen TE,  Flachs P, Hawley S, Viollet B, and Kopecký J. 2010. AMPK-activated protein kinase alpha 2 subunit is required for the preservation of hepatic insulin sensitivity by n-3 polyunsaturated fatty acids. Diabetes 59:2737-2746

 

8) Flachs P, Rühl R, Hensler M, Janovská P, Zouhar P, Kůs V, Macek Jilková Z,  Papp E, Kuda O, Svobodová M, Rossmeisl M, Tsenov G, Mohamed-Ali V, and Kopecký J. 2011. Synergistic induction of lipid catabolism and anti-inflammatory lipids in white fat of dietary obese mice in response to calorie restriction and n-3 fatty acids. Diabetologia 54: 2626-2683

 

9) Kůs V, Flachs P, Kuda O, Bardová K, Janovská P, Svobodová M, Macek Jilková Z, Rossmeisl M, Wang-Sattler R, Yu Z, Illig T, and Kopecký J. 2011. Unmasking differential effects of rosiglitazone and pioglitazone in the combination treatment with n-3 fatty acids in mice fed a high-fat diet. PLoS ONE  6(11):e27126

 

10) Horáková O, Medříková D, van Schothorst EM,  Bunschoten A, Flachs P, Kůs V, Kuda O, Bardová K, Janovská P, Hensler M, Rossmeisl M, Wang-Sattler R, Prehn C, Adamski J, Illig T, Keijer J, and Kopecký J. 2012. Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice. PLoS ONE 7(8):e43764

 

11) Flachs P, Rossmeis M, Kuda O, and Kopecký J. 2013. Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: A key to lean phenotype BBA - Molecular and Cell Biology of Lipids. Biochim Biophys Acta. 1831(5):986-1003.

 

12) Macek Jilkova Z, Hensler M, Medrikova D, Janovska P, Horakova O, Rossmeisl M, Flachs P, Sell H, Eckel J and Kopecký J. 2013. Adipose tissue-related proteins locally associated with resolution of inflammation in obese mice. Int J Obes. 1-8, Epub 2013 July 2.